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Abstract
Desmoid tumors are fibroblastic/myofibroblastic neo-
plasms, which originate from musculo-aponeurotic
structures and are classified as deep fibromatoses. De-
spite their benign histologic appearance and lack of
metastatic potential, desmoid tumors may cause aggres-
sive local infiltrations and compression of surrounding
structures. They are often associated with female gen-
der, familial adenomatous polyposis (FAP) and sporad-
ically may occur at sites of previous trauma, scars or ir-
radiation. Molecular studies have demonstrated that
these patients are associated with a bi-allelic APC mu-
tation in the affected tissue. Radical tumor resection
with free margins remains the first therapy of choice.
In cases with anatomical or technical limitations for a
wide excision, radiation therapy represents a proven
and effective alternative or supplementary treatment.
Key words: Desmoid tumors, fibromatosis, extraab-
dominal, intrathoracic, chest wall
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GENERAL DESCRIPTION
Desmoid tumors (fibromatosis) are histologically be-
nign fibroblastic/myofibroblastic neoplasms, which
originate from musculo-aponeurotic structures and are
classified as deep fibromatoses. Desmoid tumors may
arise at any site, however, the extremities, the ab-
domen and the retroperitoneum are the most common
sites of origin. In contrast, fibromatosis of the chest
wall are much less frequent. Despite their benign his-
tologic appearance and lack of metastatic potential,
desmoid tumors may cause aggressive local infiltra-
tions and compression of surrounding structures. A
high recurrence rate exists and in anatomic locations
with restricted access to surgical resections, desmoid
tumors can even lead to death [1, 2]. Desmoid tumors
are often associated with female gender, familial ade-
nomatous polyposis (FAP) and sporadically may occur
at sites of previous trauma, scars or irradiation [3-6].
Even though desmoid tumors account for only 0.03%
of all neoplasms, in patients with FAP, the estimated
prevalence rises to approximately 13% [6, 7].
HISTOLOGY
Histological examinations demonstrate long fascicles of
spindle cells of variable cell-density with few mitoses
and the absence of atypical nucleus-separations. Char-
acteristically, there is a diffuse cell infiltration of adja-
cent tissue structures. Immunohistochemically, the
spindle cells are positive for vimentin, smooth muscle
actin and muscle-specific actin, reflecting a fibroblas-
tic/myofibroblastic differentiation. Recent findings re-
vealed that virtually all deep fibromatoses exhibit so-
matic mutations of either the beta-catenin or adenoma-
tous polyposis coli (APC) gene. Consequently, all of
these tumors are immunohistochemically characterised
by diffuse nuclear beta-catenin staining [6, 21].
MOLECULAR STUDIES
Notably, molecular studies have demonstrated that
desmoid tumors in autosomal inherited FAP disease
show clonal neoplasms arising from germline muta-
tions or changes in the APC gene [1]. These are asso-
ciated with a bi-allelic APC mutation in the affected
tissue [2, 8]. In individuals lacking germline mutations
the development of desmoid tumors requires a rare
combination of events, such as at least two somatic
mutations in both alleles of a single tumor suppressor
gene, in this case the APC gene. Correspondingly, FAP
patients, exhibiting a germline mutation of the APC
gene require only a single additional somatic mutation
of the second allele of the APC gene for desmoid tu-
mor development [9].
TUMOR RESECTION
To date, radical tumor resection with free margins re-
mains the first therapy of choice. Depending on the
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jor soft tissue defects. Although abdominal wall in-
tegrity can be restored with direct sutures, reconstruc-
tion using synthetic materials is a common technique
in major abdominal and/or thoracic wall defects.
Greater wall defects not suitable for reconstruction by
local flaps can be covered by free muscle flaps.
RADIATION THERAPY
Even though radical surgical approaches are usually
favoured, radiation therapy is a suitable alternative
therapeutic option. A substantial amount of evidence
exists supporting the efficacy of radiation therapy for
the treatment of desmoid tumors [12-16]. Radiation
therapy may be used alone or in combination with
surgery, either preoperatively or postoperatively.
ALTERNATIVE THERAPEUTIC OPTIONS
Other alternative therapeutic options like anti-inflam-
matory treatments, hormone therapy and chemothera-
py have not been proven to provide any therapeutic
effectiveness. Therefore these therapies are limited to
patients, in whom resection is technically unfeasible,
e.g. due to widespread tumor infiltration.
TRANS GENE EXPRESSION THERAPY
Due to the germline mutations of the APC alleles,
pre-clinical studies of gene transfer for the treatment
of desmoid disease in FAP have been performed [11].
However, further studies are needed to assess the clin-
ical effects of trans gene expression therapy.
EXAMPLE OF ONE PATIENT STUDIED
The chest wall is the most common extraabdominal
site for desmoid tumors [17]. However, true intratho-
racic desmoid tumors are extremely rare with most
cases representing intrathoracic extension of chest
wall tumors, like the case presented below.
For this report, a review of the literature was un-
dertaken concerning chest wall and intrathoracic
desmoid tumors and we report on our surgical experi-
ence with one case of an extreme intrathoracic exten-
sion of a chest wall tumor:
A 17-year-old woman from Kosovo visiting her rela-
tives in Germany was admitted to our hospital with
chronic respiratory insufficency. She reported about a
“tumor” in her right hemithorax which had been treat-
ed previously with “alternative medicine” for the last 5
years. The CT-scan of the chest revealed complete
compression of her right lung by the tumor-mass and
a consecutive dislocation of the mediastinum (panel a,
b). Histopathological evaluation of biopsies revealed a
fibromatosis (panel e, f, g).
Intraoperatively, it became apparant that the mass
had originated from the intercostal muscle of the
right upper thorax and filled up the complete
hemithorax. Nevertheless, it was technically feasible
to completely remove the tumor including a resection
of two ribs (panel c, d). Consecutively, the small poor-
ly developed right lung was mobilised and the thoracic
wall defect was reconstructed using synthetic
materials (polypropylene net) in a common technique.
The postoperative follow up was uneventful and the
patient was discharged home on the 14th postopera-
tive day.
Histological examination of the resected specimen
revealed a tumor which consisted of elongated, slen-
der, spindle-shaped cells of uniform appearance.
These cells were embedded in abundant collagen with
little or no cell-to-cell contact. Cellular boundaries
were poorly defined. Nuclei were small, pale-staining
and sharply defined with only minute nucleoli (panel
f). The immunohistochemistry revealed a minority of
spindle shaped tumor cells, expressing the proliferative
Ki 67 antigen (panel g). Based on these characteristics
the diagnosis of an extra-abdominal fibromatosis
(desmoid tumor) was made.
DISCUSSION
Desmoid tumors involving the chest and adjacent
structures are locally aggressive tumors with a high re-
currence rate. In the literature, recurrences are strong-
ly associated with positive margins, which underlines
the need for wide radical resection of margins when-
ever possible [17]. Desmoid tumors have a remarkable
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For this reason, wide radical resection has been con-
sidered essential for successful management [20].
However, obtaining a negative margin involving the
chest region often represents a therapeutic challenge
for the surgeon. Unlike superficial chest wall desmoid
tumors which will create a palpable mass, intratho-
racic tumors will not cause symptoms until they grow
large enough to locally invade surrounding structures
or compress pulmonary parenchyma, like the case
presented herein. Thus, wide local excision is often
impossible because of surrounding vascular and neur-
al structures. Therefore, it may be advisable to consid-
er radiation therapy as an alternative or concomitant
treatment for desmoid tumors. The efficacy of radia-
tion therapy for the treatment of desmoid tumors is
supported by substantial amount of evidence [10, 12-
16]. For patients with positive margins or residual dis-
ease after surgery, adjuvant radiation therapy in com-
bination with surgery results in equivalent local con-
trol to surgery with negative margins. Thus, for pa-
tients who are not surgical candidates or who refuse
surgery, radiation therapy alone results in durable lo-
cal control rates of 70 to 80% [10, 12-16]. Disease re-
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Panel a and b: Conventional X ray and CT-scan showing
complete compression of the right lung by the tumor-mass
and consecutive dislocation of the mediastinum to the left.
Panel c: Desmoid tumor of the right hemithorax (3580 g) is
macroscopically composed of a well-defined capsule infil-
trated by a collagen network with fibrotic sections.
Panel d: Postoperative X ray: the right lung is compressed
and poorly ventilated
Panel e and f: Histological characteristics; Elongated, slen-
der, spindle-shaped tumor cells with small pale-staining nu-
clei and poorly defined boundaries are embedded in abun-
dant collagen.
Panel g: Low proliferation activity as evidenced by immuno-
histochemical detection of nuclear Ki-67 expression.
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gression may take some time after radiation therapy,
however, long-term local control rates are excellent.
Normal tissue toxicity and potential late radiation ef-
fects, including secondary malignancies, are important
considerations in the treatment of otherwise healthy,
often young patients. However, the typical radiation
dose necessary for the treatment (50 Gy) does not ex-
ceed bowel tolerance and is associated with a low risk
of complications [15]. Furthermore, the use of mod-
ern, conformal radiation treatment planning tech-
niques allows for a minimization of normal tissue
dose. When considering disease progression that
could result in significant morbidity and mortality, the
potential benefits of radiation therapy clearly out-
weigh the risks.
In conclusion, primary radical resection with nega-
tive margins remains the principal determinant of out-
come for intrathoracic or chest wall desmoid tumors.
Positive margins after surgery reflect a high risk for lo-
cal recurrence. Thus, in cases with anatomical or tech-
nical limitations for a wide excision, it may be advis-
able to consider radiation therapy as an alternative or
concomitant treatment. Radiation therapy represents a
proven and effective therapy for this disorder.
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